New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 11, 2013
16:08 EDTCRMDCorMedix files to sell 3.78M shares of common stock for holders
News For CRMD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 19, 2015
14:44 EDTCRMDCourt finds TauroPharm infringed CorMedix patent, utility models
In a regulatory filing earlier, CorMedix announced that it has received written copies of the May 8 decisions of the District Court of Mannheim on CorMedix's patent and utility model infringement cases in Germany related to Neutrolin. The written decisions confirm that the two proceedings brought by CorMedix against TauroPharm have been stayed. The court found that the commercialization by TauroPharm in Germany of its TauroLock catheter lock solutions Hep100 and Hep500 infringes both CorMedix’s patent and utility model, and further that there is no prior use right that would allow TauroPharm to continue to make, use or sell its product in Germany. However, the court declined to issue an injunction based on the likelihood that the European Patent Office, in the case of the patent, or the German Patent and Trademark Office, in the case of the utility model, may find that the patent or utility model is invalid. The court noted the possible publication of certain instructions for product use that may be deemed to constitute prior art. As such, the court will defer consideration of injunction until the EPO or German PTO rules on the underlying validity of the patent/utility model. CorMedix continues to believe that the patent and utility model validly claims inventions.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use